LSA
AGL icon

Leonteq Securities AG’s Agilon Health AGL Stock Holding History

Leonteq Securities AG’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30
Closed -$512 – 1288
2025
Q4 		$512 Sell
30
-190
-86% -$3.68K ﹤0.01% 1368
2025
Q3 		$5.67K Hold
220
– – ﹤0.01% 1154
2025
Q2 		$12.7K Hold
220
– – ﹤0.01% 1033
2025
Q1 		$23.8K Sell
220
-273
-55% -$23.8K ﹤0.01% 960
2024
Q4 		$23.4K Buy
493
+203
+70% +$12.3K ﹤0.01% 951
2024
Q3 		$28.5K Sell
290
-1,356
-82% -$175K ﹤0.01% 865
2024
Q2 		$269K Sell
1,646
-251
-13% -$35.8K 0.02% 420
2024
Q1 		$289K Buy
1,897
+1,652
+674% +$275K 0.02% 419
2023
Q4 		$76.9K Buy
+245
New +$88.7K ﹤0.01% 687
2021
Q4 		– Sell
-28
Closed -$18.1K – 1254
2021
Q3 		$18.1K Buy
+28
New +$23.9K ﹤0.01% 1008

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Leonteq Securities AG's AGL Position: Q1 2026 in Review

Leonteq Securities AG sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 30 shares — an estimated $512 sold.

Leonteq Securities AG first reported a position in AGL in Q3 2021 and held it in 10 quarters. The position peaked at $289K in Q1 2024. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Leonteq Securities AG reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Leonteq Securities AG sold 30 Agilon Health shares in Q1 2026, an estimated $512.
  • Leonteq Securities AG first reported a position in Agilon Health in Q3 2021 and held it in 10 quarters.
  • Leonteq Securities AG's Agilon Health position peaked at $289K in Q1 2024.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Leonteq Securities AG's 13F filing for Q1 2026, filed 27 Apr 2026.